Clinical trials: Image-guide Surgery
Hepatocellular Carcinoma
GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma
This study is to evaluate whether intraoperative fluorescence imaging targeting GPC3 can aid improve the surgical accuracy of hepatocellular carcinoma.
- Trial name
- NCT05047510
- Testing
- Anti-GPC3-IRDye800CW
- Where
- 2 sites in China
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Chinese Academy of Sciences
Endovascular
Evaluation of the Clinical and Cost-effectiveness of an Automated Mobile Hybrid Room in Vascular Surgery Compared with Current Practice
Evaluation of the clinical and cost-effectiveness of a mobile hybrid room compared with current practice without mobile hybrid room and imaging fusion guidance, in a French multicentre clinical setting.
- Trial name
- RADIOPROTEC (NCT06590532)
- Testing
- Endovascular aneurysm repair or aorto iliac endovascular revascularisation with Fusion imaging system Cydar-EV, Endovascular aneurysm repair or aorto iliac endovascular revascularisation without Fusion imaging system Cydar-EV
- Where
- 7 sites in France
- Volunteers
- 350 people
- Sponsor
- Nantes University Hospital
Hepatic Carcinoma
Arterial Base Fluorescence Segmental Positive Staining
More and more laparoscopic hepatectomy were performed due to increasing experience, well designed instruments and energy device.
- Trial name
- NCT04266548
- Testing
- Superselective Intra-arterial Hepatic Injection of Indocyanine Green (ICG) for Fluorescence Image-guided Segmental Positive Staining
- Where
- Taiwan
- Volunteers
- 8 people
- Sponsor
- Chang Gung Memorial Hospital
Image-guide Surgery, Lymph Node Metastasis
Navigated Abdominal Lymph Node Dissections
Image-guided navigation surgery allows for full utilization of pre-operative imaging during surgery, and has the potential of reducing both irradical resections and morbidity.
- Trial name
- N16LND (NCT05867095)
- Testing
- Surgical navigation, Conventional
- Where
- Netherlands
- Volunteers
- 69 people
- Sponsor
- The Netherlands Cancer Institute
Prostate Cancer
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
The purpose of this study is to see whether using the copper-64 (64Cu) or zirconium-89 (89Zr) radiolabeled PSMA-targeting C' dot tracer, termed 64Cu-NOTA-PSMAi-PEG-Cy5.5-C' dots or 89Zr-DFO-PSMAi-PEG-Cy5.5-C' dots, is a safe way…
- Trial name
- NCT04167969
- Testing
- (64Cu)-NOTA-PSMAi-PEG-Cy5.5-C' dot tracer, PET/MRI/fluorescence imaging, Blood and urine sampling
- Where
- 2 sites in United States
- Volunteers
- 16 people
- Sponsor
- Memorial Sloan Kettering Cancer Center